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Chemical Formula: C29H24N4O5 
Exact Mass: 508.1747 
Molecular Weight: 508.5340 
m/z: 508.1747 (100.0%), 509.1780 (31.4%), 510.1814 
(2.7%), 510.1814 (2.0%), 509.1717 (1.5%), 510.1789 
(1.0%) 
Elemental Analysis: C, 68.49; H, 4.76; N, 11.02; O, 15.73 
	
Chemical Formula: C31H26N4O7 
Exact Mass: 566.1801 
Molecular Weight: 566.5700 
m/z: 566.1801 (100.0%), 567.1835 (33.5%), 568.1869 
(2.7%), 568.1869 (2.7%), 567.1772 (1.5%), 568.1844 
(1.4%) 
Elemental Analysis: C, 65.72; H, 4.63; N, 9.89; O, 19.77 
Chemical Formula: C17H18N2O2 
Exact Mass: 282.1368 
Molecular Weight: 282.3430 
m/z: 282.1368 (100.0%), 283.1402 (18.4%), 284.1435 
(1.6%) 




Leaving group: 60 
Chemical Formula: C2H4O2 
Exact Mass: 60.02 
Molecular Weight: 60.05 
m/z: 60.02 (100.0%), 61.02 (2.2%) 







Leaving group: 225 
Chemical Formula: C12H8N2O3 
Exact Mass: 228.0535 
Molecular Weight: 228.2070 
m/z: 228.0535 (100.0%), 229.0568 (13.0%) 

































Chemical Formula: C30H35N5O4 
Exact Mass: 529.2689 
Molecular Weight: 529.6410 
m/z: 529.2689 (100.0%), 530.2723 (32.4%), 531.2756 
(2.7%), 531.2756 (2.4%), 530.2659 (1.8%) 
Elemental Analysis: C, 68.03; H, 6.66; N, 13.22; O, 12.08 
Chemical Formula: C32H37N5O6 
Exact Mass: 587.2744 
Molecular Weight: 587.6770 
m/z: 587.2744 (100.0%), 588.2777 (34.6%), 589.2811 
(5.8%), 588.2714 (1.8%), 589.2786 (1.2%) 
Elemental Analysis: C, 65.40; H, 6.35; N, 11.92; O, 16.33 
Chemical Formula: C17H23N3O2 
Exact Mass: 301.1790 
Molecular Weight: 301.3900 
m/z: 301.1790 (100.0%), 302.1824 (18.4%), 303.1857 
(1.6%), 302.1761 (1.1%) 
Elemental Analysis: C, 67.75; H, 7.69; N, 13.94; O, 10.62 
O
OH
Leaving group: 60 
Chemical Formula: C2H4O2 
Exact Mass: 60.02 
Molecular Weight: 60.05 
m/z: 60.02 (100.0%), 61.02 (2.2%) 
Elemental Analysis: C, 40.00; H, 6.71; O, 53.28 
Leaving group: 225 
Chemical Formula: C13H14N2O2 
Exact Mass: 230.1055 
Molecular Weight: 230.2670 
m/z: 230.1055 (100.0%), 231.1089 (14.1%) 




































































Chemical Formula: C32H37N5O4 
Exact Mass: 555.2846 
Molecular Weight: 555.6790 
m/z: 555.2846 (100.0%), 556.2879 (34.6%), 557.2913 
(5.8%), 556.2816 (1.8%) 
Elemental Analysis: C, 69.17; H, 6.71; N, 12.60; O, 11.52 
Chemical Formula: C34H39N5O6 
Exact Mass: 613.2900 
Molecular Weight: 613.7150 
m/z: 613.2900 (100.0%), 614.2934 (36.8%), 615.2967 
(6.6%), 614.2871 (1.8%), 615.2943 (1.2%) 
Elemental Analysis: C, 66.54; H, 6.41; N, 11.41; O, 15.64 
Chemical Formula: C19H25N3O2 
Exact Mass: 327.1947 
Molecular Weight: 327.4280 
m/z: 327.1947 (100.0%), 328.1980 (20.5%), 329.2014 
(2.0%), 328.1917 (1.1%) 
Elemental Analysis: C, 69.70; H, 7.70; N, 12.83; O, 9.77 
O
OH
Leaving group: 60 
Chemical Formula: C2H4O2 
Exact Mass: 60.02 
Molecular Weight: 60.05 
m/z: 60.02 (100.0%), 61.02 (2.2%) 
Elemental Analysis: C, 40.00; H, 6.71; O, 53.28 
Leaving group: 225 
Chemical Formula: C13H14N2O2 
Exact Mass: 230.1055 
Molecular Weight: 230.2670 
m/z: 230.1055 (100.0%), 231.1089 (14.1%) 




































































Chemical Formula: C33H40N4O4 
Exact Mass: 556.3050 
Molecular Weight: 556.7070 
m/z: 556.3050 (100.0%), 557.3083 (35.7%), 558.3117 
(3.5%), 558.3117 (2.7%), 557.3020 (1.5%) 
Elemental Analysis: C, 71.20; H, 7.24; N, 10.06; O, 11.50 
Chemical Formula: C35H42N4O6 
Exact Mass: 614.3104 
Molecular Weight: 614.7430 
m/z: 614.3104 (100.0%), 615.3138 (37.9%), 616.3171 
(7.0%), 615.3075 (1.5%), 616.3147 (1.2%) 
Elemental Analysis: C, 68.38; H, 6.89; N, 9.11; O, 15.62 
Chemical Formula: C20H28N2O2 
Exact Mass: 328.2151 
Molecular Weight: 328.4560 
m/z: 328.2151 (100.0%), 329.2184 (21.6%), 330.2218 
(2.2%) 
Elemental Analysis: C, 73.14; H, 8.59; N, 8.53; O, 9.74 
O
OH
Leaving group: 60 
Chemical Formula: C2H4O2 
Exact Mass: 60.02 
Molecular Weight: 60.05 
m/z: 60.02 (100.0%), 61.02 (2.2%) 
Elemental Analysis: C, 40.00; H, 6.71; O, 53.28 
Leaving group: 225 
Chemical Formula: C13H14N2O2 
Exact Mass: 230.1055 
Molecular Weight: 230.2670 
m/z: 230.1055 (100.0%), 231.1089 (14.1%) 

































































Chemical Formula: C31H25N4O6+ 
Exact Mass: 549.18 
Molecular Weight: 549.56 
m/z: 549.18 (100.0%), 550.18 (33.5%), 551.18 (5.4%), 
550.17 (1.5%), 551.18 (1.2%) 
Elemental Analysis: C, 67.75; H, 4.59; N, 10.20; O, 17.47 
Chemical Formula: C31H28N4O7+ 
Exact Mass: 568.20 
Molecular Weight: 568.59 
m/z: 568.20 (100.0%), 569.20 (33.5%), 570.20 (2.7%), 
570.20 (2.7%), 569.19 (1.5%), 570.20 (1.4%) 
Elemental Analysis: C, 65.49; H, 4.96; N, 9.85; O, 19.70 
Chemical Formula: C29H23N4O4+ 
Exact Mass: 491.17 
Molecular Weight: 491.53 
m/z: 491.17 (100.0%), 492.17 (31.4%), 493.18 (2.7%), 
493.18 (2.0%), 492.17 (1.5%) 
Elemental Analysis: C, 70.86; H, 4.72; N, 11.40; O, 13.02 
O
OH
Leaving group: 18 
 
Leaving group: 59 
Chemical Formula: C2H4O2 
Exact Mass: 60.02 
Molecular Weight: 60.05 
m/z: 60.02 (100.0%), 61.02 (2.2%) 
Elemental Analysis: C, 40.00; H, 6.71; O, 53.28 
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4. CONCLUSIONS	
	
This	study	aimed	to	identify	and	isolate	secondary	metabolites	from	the	bryozoan	
Cryptosula	zavjalovensis	from	Hokkaido,	Japan.	There	have	been	no	previous	studies	on	the	
natural	products	from	this	bryozoan	species	and	these	compounds	are	of	interest	for	their	
bioactivity.	Specifically,	it	aimed	to	determine	if	these	compounds	are	bioactive	and	if	this	
bioactivity	might	translate	into	medicinal	and	pharmaceutical	applications	through	
cytotoxicity	testing.	
	
From	these	objectives,	it	can	be	concluded	from	this	study	that:	
	
Secondary	metabolites	similar	to	that	of	pterocellin	E	have	been	identified.	The	elucidation	
of	the	structure	of	these	compounds,	however,	are	still	at	the	early	stages	using	tandem	
mass	spectrometry	and	are	thus	not	definitive.	The	structures	proposed	are	based	merely	
on	the	similarities	of	the	properties	of	the	identified	compounds	and	that	of	pterocellin	E.	
Further	tests	that	can	be	used	to	elucidate	the	structure	include	Infrared	(IR)	spectroscopy	
and	carbon-13	nuclear	magnetic	resonance	(13C	NMR)	to	identify	functional	groups	and	
proton	nuclear	magnetic	resonance	(H	NMR)	to	identify	molecular	fragments.	
	
Compounds	extracted	from	Cryptosula	zavjalovensis	are	bioactive.	The	cytotoxicity	
screening	showed	that	the	bioactive	compounds	are	contained	in	the	organic	extract,	
specifically	in	fractions	E2	and	E3.	At	a	concentration	of	1	µg/mL	fraction	E3	exhibited	58%	
cytotoxicity	while	at	a	concentration	of	10	µg/mL	fraction	E2	exhibited	79%	cytotoxicity	
whereas	E3	exhibited	107%	cytotoxicity	against	MCF-7	breast	cancer	cells.	In	order	to	better	
understand	the	bioactivity	and	cytotoxicity	of	these	extracts,	it	is	suggested	that	further	
cytotoxicity	tests	should	be	done	on	other	cell	lines.	
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